Two Sigma Investments, LP Cytokinetics Inc Transaction History

Two Sigma Investments, LP

  • $41.1 Billion
  • Q2 2024

A detailed history of Two Sigma Investments, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 58,600 shares of CYTK stock, worth $3.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
58,600
Previous 85,345 31.34%
Holding current value
$3.08 Million
Previous $5.98 Million 46.95%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$47.86 - $75.05 $1.28 Million - $2.01 Million
-26,745 Reduced 31.34%
58,600 $3.17 Million
Q1 2024

May 15, 2024
SELL
$63.75 - $108.06 $414,056 - $701,849
-6,495 Reduced 7.07%
85,345 $5.98 Million
Q4 2023

Feb 14, 2024
SELL
$26.88 - $83.49 $129,642 - $402,672
-4,823 Reduced 4.99%
91,840 $7.67 Million
Q3 2023

Nov 14, 2023
BUY
$29.46 - $36.61 $1.59 Million - $1.98 Million
54,063 Added 126.91%
96,663 $2.85 Million
Q2 2023

Aug 14, 2023
SELL
$32.62 - $40.75 $5.63 Million - $7.03 Million
-172,483 Reduced 80.19%
42,600 $1.39 Million
Q1 2023

May 15, 2023
BUY
$33.36 - $45.71 $1.32 Million - $1.81 Million
39,622 Added 22.58%
215,083 $7.57 Million
Q4 2022

Feb 14, 2023
BUY
$35.77 - $51.11 $5.47 Million - $7.82 Million
152,910 Added 678.06%
175,461 $8.04 Million
Q3 2022

Nov 14, 2022
BUY
$38.54 - $54.52 $869,115 - $1.23 Million
22,551 New
22,551 $1.09 Million
Q2 2022

Aug 15, 2022
SELL
$33.93 - $48.92 $2.96 Million - $4.27 Million
-87,325 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$29.74 - $46.0 $14.9 Million - $23.1 Million
-501,416 Reduced 85.17%
87,325 $3.21 Million
Q4 2021

Feb 14, 2022
SELL
$34.35 - $46.38 $3.09 Million - $4.17 Million
-89,833 Reduced 13.24%
588,741 $26.8 Million
Q3 2021

Nov 15, 2021
BUY
$18.54 - $35.74 $4.97 Million - $9.59 Million
268,331 Added 65.41%
678,574 $24.3 Million
Q2 2021

Aug 16, 2021
SELL
$19.79 - $26.99 $2.69 Million - $3.67 Million
-135,972 Reduced 24.89%
410,243 $8.12 Million
Q1 2021

May 17, 2021
BUY
$18.57 - $25.68 $7.89 Million - $10.9 Million
424,969 Added 350.5%
546,215 $12.7 Million
Q4 2020

Feb 16, 2021
SELL
$15.26 - $28.61 $8.34 Million - $15.6 Million
-546,828 Reduced 81.85%
121,246 $2.52 Million
Q3 2020

Nov 16, 2020
BUY
$20.58 - $28.96 $4.72 Million - $6.64 Million
229,286 Added 52.25%
668,074 $14.5 Million
Q2 2020

Aug 14, 2020
BUY
$11.15 - $24.64 $743,660 - $1.64 Million
66,696 Added 17.92%
438,788 $10.3 Million
Q1 2020

May 15, 2020
SELL
$8.75 - $16.3 $790,632 - $1.47 Million
-90,358 Reduced 19.54%
372,092 $4.39 Million
Q4 2019

Feb 14, 2020
BUY
$7.95 - $11.84 $2.73 Million - $4.06 Million
342,980 Added 287.08%
462,450 $4.91 Million
Q3 2019

Nov 14, 2019
SELL
$10.82 - $14.25 $1.61 Million - $2.12 Million
-148,745 Reduced 55.46%
119,470 $1.36 Million
Q2 2019

Aug 14, 2019
SELL
$7.95 - $11.25 $939,666 - $1.33 Million
-118,197 Reduced 30.59%
268,215 $3.02 Million
Q1 2019

May 15, 2019
BUY
$5.95 - $10.19 $2.03 Million - $3.48 Million
341,170 Added 754.1%
386,412 $3.13 Million
Q4 2018

Feb 14, 2019
BUY
$5.91 - $9.29 $77,787 - $122,274
13,162 Added 41.03%
45,242 $286,000
Q3 2018

Nov 14, 2018
BUY
$6.4 - $9.85 $205,312 - $315,988
32,080 New
32,080 $316,000
Q2 2018

Aug 14, 2018
SELL
$6.9 - $9.9 $425,564 - $610,592
-61,676 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$7.2 - $10.05 $376,027 - $524,871
-52,226 Reduced 45.85%
61,676 $444,000
Q4 2017

Feb 14, 2018
BUY
$7.25 - $15.65 $595,174 - $1.28 Million
82,093 Added 258.08%
113,902 $928,000
Q3 2017

Nov 14, 2017
BUY
$12.0 - $15.0 $381,708 - $477,135
31,809
31,809 $461,000

Others Institutions Holding CYTK

# of Institutions
406
Shares Held
126M
Call Options Held
3.29M
Put Options Held
2.01M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.95B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email